nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—Biliary sludge—Octreotide—thymus cancer	0.216	0.333	CcSEcCtD
Sulindac—PTGDR2—hematopoietic system—thymus cancer	0.0302	0.0941	CbGeAlD
Sulindac—Cholecystitis—Octreotide—thymus cancer	0.018	0.0277	CcSEcCtD
Sulindac—Cholelithiasis—Octreotide—thymus cancer	0.0166	0.0256	CcSEcCtD
Sulindac—AKR1B1—hematopoietic system—thymus cancer	0.016	0.05	CbGeAlD
Sulindac—MAPK3—neck—thymus cancer	0.0156	0.0487	CbGeAlD
Sulindac—Peptic ulcer—Octreotide—thymus cancer	0.0155	0.0238	CcSEcCtD
Sulindac—AKR1B1—epithelium—thymus cancer	0.0147	0.0457	CbGeAlD
Sulindac—Neuritis—Octreotide—thymus cancer	0.0138	0.0213	CcSEcCtD
Sulindac—Cholestasis—Octreotide—thymus cancer	0.0136	0.021	CcSEcCtD
Sulindac—Nephrolithiasis—Octreotide—thymus cancer	0.0129	0.0198	CcSEcCtD
Sulindac—PPARD—hematopoietic system—thymus cancer	0.0126	0.0393	CbGeAlD
Sulindac—AKR1B1—cardiac atrium—thymus cancer	0.0122	0.038	CbGeAlD
Sulindac—AKR1B1—pituitary gland—thymus cancer	0.0119	0.0371	CbGeAlD
Sulindac—MAPK3—hematopoietic system—thymus cancer	0.0116	0.0362	CbGeAlD
Sulindac—AKR1B1—lymphoid tissue—thymus cancer	0.0113	0.0352	CbGeAlD
Sulindac—Hearing impaired—Octreotide—thymus cancer	0.0109	0.0167	CcSEcCtD
Sulindac—MAPK3—epithelium—thymus cancer	0.0106	0.0331	CbGeAlD
Sulindac—AKR1B1—bone marrow—thymus cancer	0.0103	0.0321	CbGeAlD
Sulindac—AKR1B1—thyroid gland—thymus cancer	0.0103	0.032	CbGeAlD
Sulindac—Hyperkalaemia—Octreotide—thymus cancer	0.0102	0.0156	CcSEcCtD
Sulindac—AKR1B1—lung—thymus cancer	0.00932	0.029	CbGeAlD
Sulindac—Gynaecomastia—Octreotide—thymus cancer	0.00925	0.0142	CcSEcCtD
Sulindac—PPARD—lymphoid tissue—thymus cancer	0.00888	0.0277	CbGeAlD
Sulindac—MAPK3—cardiac atrium—thymus cancer	0.00883	0.0275	CbGeAlD
Sulindac—MAPK3—pituitary gland—thymus cancer	0.00863	0.0269	CbGeAlD
Sulindac—Gastroenteritis—Octreotide—thymus cancer	0.00847	0.013	CcSEcCtD
Sulindac—Cardiac failure congestive—Octreotide—thymus cancer	0.00828	0.0127	CcSEcCtD
Sulindac—MAPK3—lymphoid tissue—thymus cancer	0.00819	0.0255	CbGeAlD
Sulindac—PPARD—thyroid gland—thymus cancer	0.00807	0.0251	CbGeAlD
Sulindac—Visual disturbance—Octreotide—thymus cancer	0.00792	0.0122	CcSEcCtD
Sulindac—Arthritis—Octreotide—thymus cancer	0.00772	0.0119	CcSEcCtD
Sulindac—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00751	0.0116	CcSEcCtD
Sulindac—MAPK3—bone marrow—thymus cancer	0.00746	0.0232	CbGeAlD
Sulindac—MAPK3—thyroid gland—thymus cancer	0.00744	0.0232	CbGeAlD
Sulindac—PPARD—lung—thymus cancer	0.00733	0.0228	CbGeAlD
Sulindac—MAPK3—lung—thymus cancer	0.00676	0.0211	CbGeAlD
Sulindac—Gastritis—Octreotide—thymus cancer	0.00664	0.0102	CcSEcCtD
Sulindac—Muscular weakness—Octreotide—thymus cancer	0.00662	0.0102	CcSEcCtD
Sulindac—Bronchospasm—Octreotide—thymus cancer	0.00638	0.00982	CcSEcCtD
Sulindac—AKR1B1—lymph node—thymus cancer	0.00637	0.0199	CbGeAlD
Sulindac—Pancreatitis—Octreotide—thymus cancer	0.00636	0.00979	CcSEcCtD
Sulindac—Sweating increased—Octreotide—thymus cancer	0.00632	0.00973	CcSEcCtD
Sulindac—Dysuria—Octreotide—thymus cancer	0.00607	0.00934	CcSEcCtD
Sulindac—Hyperglycaemia—Octreotide—thymus cancer	0.00585	0.00901	CcSEcCtD
Sulindac—Pneumonia—Octreotide—thymus cancer	0.00582	0.00895	CcSEcCtD
Sulindac—Depression—Octreotide—thymus cancer	0.00577	0.00888	CcSEcCtD
Sulindac—Neuropathy peripheral—Octreotide—thymus cancer	0.00567	0.00873	CcSEcCtD
Sulindac—Jaundice—Octreotide—thymus cancer	0.00564	0.00868	CcSEcCtD
Sulindac—Conjunctivitis—Octreotide—thymus cancer	0.00562	0.00865	CcSEcCtD
Sulindac—Haematuria—Octreotide—thymus cancer	0.00551	0.00849	CcSEcCtD
Sulindac—Epistaxis—Octreotide—thymus cancer	0.00546	0.0084	CcSEcCtD
Sulindac—Hepatitis—Octreotide—thymus cancer	0.00519	0.00799	CcSEcCtD
Sulindac—PPARD—lymph node—thymus cancer	0.00501	0.0156	CbGeAlD
Sulindac—Visual impairment—Octreotide—thymus cancer	0.005	0.0077	CcSEcCtD
Sulindac—Tinnitus—Octreotide—thymus cancer	0.00484	0.00745	CcSEcCtD
Sulindac—Flushing—Octreotide—thymus cancer	0.00482	0.00742	CcSEcCtD
Sulindac—Arrhythmia—Octreotide—thymus cancer	0.00464	0.00714	CcSEcCtD
Sulindac—MAPK3—lymph node—thymus cancer	0.00462	0.0144	CbGeAlD
Sulindac—Alopecia—Octreotide—thymus cancer	0.00459	0.00706	CcSEcCtD
Sulindac—Flatulence—Octreotide—thymus cancer	0.00445	0.00686	CcSEcCtD
Sulindac—Tension—Octreotide—thymus cancer	0.00444	0.00683	CcSEcCtD
Sulindac—Nervousness—Octreotide—thymus cancer	0.00439	0.00676	CcSEcCtD
Sulindac—Vision blurred—Octreotide—thymus cancer	0.00426	0.00656	CcSEcCtD
Sulindac—Ill-defined disorder—Octreotide—thymus cancer	0.00419	0.00645	CcSEcCtD
Sulindac—Anaemia—Octreotide—thymus cancer	0.00418	0.00643	CcSEcCtD
Sulindac—Malaise—Octreotide—thymus cancer	0.00408	0.00627	CcSEcCtD
Sulindac—Vertigo—Octreotide—thymus cancer	0.00406	0.00625	CcSEcCtD
Sulindac—Syncope—Octreotide—thymus cancer	0.00405	0.00624	CcSEcCtD
Sulindac—Palpitations—Octreotide—thymus cancer	0.00399	0.00615	CcSEcCtD
Sulindac—Loss of consciousness—Octreotide—thymus cancer	0.00397	0.00611	CcSEcCtD
Sulindac—Convulsion—Octreotide—thymus cancer	0.00392	0.00603	CcSEcCtD
Sulindac—Hypertension—Octreotide—thymus cancer	0.0039	0.00601	CcSEcCtD
Sulindac—Chest pain—Octreotide—thymus cancer	0.00385	0.00592	CcSEcCtD
Sulindac—Arthralgia—Octreotide—thymus cancer	0.00385	0.00592	CcSEcCtD
Sulindac—Myalgia—Octreotide—thymus cancer	0.00385	0.00592	CcSEcCtD
Sulindac—Discomfort—Octreotide—thymus cancer	0.0038	0.00585	CcSEcCtD
Sulindac—Anaphylactic shock—Octreotide—thymus cancer	0.00369	0.00568	CcSEcCtD
Sulindac—Oedema—Octreotide—thymus cancer	0.00369	0.00568	CcSEcCtD
Sulindac—CYP1A2—hematopoietic system—thymus cancer	0.00365	0.0114	CbGeAlD
Sulindac—Shock—Octreotide—thymus cancer	0.00363	0.00559	CcSEcCtD
Sulindac—Thrombocytopenia—Octreotide—thymus cancer	0.00361	0.00556	CcSEcCtD
Sulindac—Tachycardia—Octreotide—thymus cancer	0.0036	0.00554	CcSEcCtD
Sulindac—CYP1A1—hematopoietic system—thymus cancer	0.0036	0.0112	CbGeAlD
Sulindac—Hyperhidrosis—Octreotide—thymus cancer	0.00357	0.00549	CcSEcCtD
Sulindac—Anorexia—Octreotide—thymus cancer	0.00352	0.00541	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00336	0.00517	CcSEcCtD
Sulindac—Insomnia—Octreotide—thymus cancer	0.00334	0.00514	CcSEcCtD
Sulindac—Paraesthesia—Octreotide—thymus cancer	0.00331	0.0051	CcSEcCtD
Sulindac—CYP1A1—epithelium—thymus cancer	0.00329	0.0102	CbGeAlD
Sulindac—Dyspnoea—Octreotide—thymus cancer	0.00329	0.00506	CcSEcCtD
Sulindac—Somnolence—Octreotide—thymus cancer	0.00328	0.00505	CcSEcCtD
Sulindac—Dyspepsia—Octreotide—thymus cancer	0.00325	0.005	CcSEcCtD
Sulindac—Decreased appetite—Octreotide—thymus cancer	0.00321	0.00494	CcSEcCtD
Sulindac—Fatigue—Octreotide—thymus cancer	0.00318	0.0049	CcSEcCtD
Sulindac—PTGS1—hematopoietic system—thymus cancer	0.00316	0.00985	CbGeAlD
Sulindac—Constipation—Octreotide—thymus cancer	0.00315	0.00486	CcSEcCtD
Sulindac—Feeling abnormal—Octreotide—thymus cancer	0.00304	0.00468	CcSEcCtD
Sulindac—PTGS2—hematopoietic system—thymus cancer	0.00302	0.00941	CbGeAlD
Sulindac—Gastrointestinal pain—Octreotide—thymus cancer	0.00302	0.00464	CcSEcCtD
Sulindac—Urticaria—Octreotide—thymus cancer	0.00293	0.00451	CcSEcCtD
Sulindac—Body temperature increased—Octreotide—thymus cancer	0.00292	0.00449	CcSEcCtD
Sulindac—PTGS1—epithelium—thymus cancer	0.00289	0.009	CbGeAlD
Sulindac—PTGS2—epithelium—thymus cancer	0.00276	0.00861	CbGeAlD
Sulindac—CYP1A1—cardiac atrium—thymus cancer	0.00273	0.00851	CbGeAlD
Sulindac—Hypersensitivity—Octreotide—thymus cancer	0.00272	0.00418	CcSEcCtD
Sulindac—Asthenia—Octreotide—thymus cancer	0.00265	0.00407	CcSEcCtD
Sulindac—Pruritus—Octreotide—thymus cancer	0.00261	0.00402	CcSEcCtD
Sulindac—Diarrhoea—Octreotide—thymus cancer	0.00252	0.00388	CcSEcCtD
Sulindac—Dizziness—Octreotide—thymus cancer	0.00244	0.00375	CcSEcCtD
Sulindac—PTGS1—cardiac atrium—thymus cancer	0.0024	0.00748	CbGeAlD
Sulindac—Vomiting—Octreotide—thymus cancer	0.00235	0.00361	CcSEcCtD
Sulindac—PTGS1—pituitary gland—thymus cancer	0.00234	0.00731	CbGeAlD
Sulindac—CYP1A2—thyroid gland—thymus cancer	0.00233	0.00727	CbGeAlD
Sulindac—Rash—Octreotide—thymus cancer	0.00233	0.00358	CcSEcCtD
Sulindac—Dermatitis—Octreotide—thymus cancer	0.00232	0.00358	CcSEcCtD
Sulindac—Headache—Octreotide—thymus cancer	0.00231	0.00356	CcSEcCtD
Sulindac—CYP1A1—thyroid gland—thymus cancer	0.0023	0.00717	CbGeAlD
Sulindac—PTGS2—pituitary gland—thymus cancer	0.00224	0.00698	CbGeAlD
Sulindac—ALB—lymph node—thymus cancer	0.0022	0.00687	CbGeAlD
Sulindac—Nausea—Octreotide—thymus cancer	0.00219	0.00337	CcSEcCtD
Sulindac—PTGS2—lymphoid tissue—thymus cancer	0.00213	0.00663	CbGeAlD
Sulindac—CYP1A2—lung—thymus cancer	0.00212	0.0066	CbGeAlD
Sulindac—CYP1A1—lung—thymus cancer	0.00209	0.00651	CbGeAlD
Sulindac—PTGS1—thyroid gland—thymus cancer	0.00202	0.0063	CbGeAlD
Sulindac—PTGS2—bone marrow—thymus cancer	0.00194	0.00604	CbGeAlD
Sulindac—PTGS1—lung—thymus cancer	0.00184	0.00572	CbGeAlD
Sulindac—PTGS2—lung—thymus cancer	0.00175	0.00547	CbGeAlD
Sulindac—CYP1A1—lymph node—thymus cancer	0.00143	0.00445	CbGeAlD
Sulindac—PTGS1—lymph node—thymus cancer	0.00126	0.00391	CbGeAlD
Sulindac—PTGS2—lymph node—thymus cancer	0.0012	0.00374	CbGeAlD
Sulindac—MAPK3—Axon guidance—DPYSL5—thymus cancer	0.000704	0.0239	CbGpPWpGaD
Sulindac—MAPK3—Oncogene Induced Senescence—CDKN2A—thymus cancer	0.000584	0.0199	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—CYLD—thymus cancer	0.000575	0.0196	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling in naïve CD8+ T cells—CD8A—thymus cancer	0.00051	0.0173	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—DPYSL5—thymus cancer	0.000502	0.0171	CbGpPWpGaD
Sulindac—MAPK3—Signaling events mediated by Stem cell factor receptor (c-Kit)—KIT—thymus cancer	0.00047	0.016	CbGpPWpGaD
Sulindac—MAPK3—Kit receptor signaling pathway—KIT—thymus cancer	0.000419	0.0142	CbGpPWpGaD
Sulindac—MAPK3—IL-5 Signaling Pathway—IL2—thymus cancer	0.000402	0.0137	CbGpPWpGaD
Sulindac—MAPK3—TCR Signaling Pathway—CD8A—thymus cancer	0.000398	0.0135	CbGpPWpGaD
Sulindac—MAPK3—IL-2 Signaling Pathway—IL2—thymus cancer	0.000387	0.0132	CbGpPWpGaD
Sulindac—MAPK3—Interleukin-2 signaling—IL2—thymus cancer	0.000353	0.012	CbGpPWpGaD
Sulindac—PPARD—Generic Transcription Pathway—MAML2—thymus cancer	0.000345	0.0117	CbGpPWpGaD
Sulindac—MAPK3—Oncogene Induced Senescence—TP53—thymus cancer	0.000325	0.0111	CbGpPWpGaD
Sulindac—MAPK3—IL-7 Signaling Pathway—AKT1—thymus cancer	0.000318	0.0108	CbGpPWpGaD
Sulindac—MAPK3—S1P3 pathway—AKT1—thymus cancer	0.000318	0.0108	CbGpPWpGaD
Sulindac—MAPK3—Signal Transduction of S1P Receptor—AKT1—thymus cancer	0.000318	0.0108	CbGpPWpGaD
Sulindac—MAPK3—VEGFR3 signaling in lymphatic endothelium—AKT1—thymus cancer	0.000318	0.0108	CbGpPWpGaD
Sulindac—MAPK3—IL2-mediated signaling events—IL2—thymus cancer	0.000316	0.0108	CbGpPWpGaD
Sulindac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—thymus cancer	0.000309	0.0105	CbGpPWpGaD
Sulindac—MAPK3—EPO Receptor Signaling—AKT1—thymus cancer	0.000308	0.0105	CbGpPWpGaD
Sulindac—MAPK3—FSH signaling pathway—AKT1—thymus cancer	0.000299	0.0102	CbGpPWpGaD
Sulindac—MAPK3—VEGFR1 specific signals—AKT1—thymus cancer	0.000282	0.00959	CbGpPWpGaD
Sulindac—MAPK3—Retinoic acid receptors-mediated signaling—AKT1—thymus cancer	0.000274	0.00934	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling in naïve CD8+ T cells—IL2—thymus cancer	0.000269	0.00916	CbGpPWpGaD
Sulindac—MAPK3—IL17 signaling pathway—AKT1—thymus cancer	0.000267	0.00909	CbGpPWpGaD
Sulindac—MAPK3—Nongenotropic Androgen signaling—AKT1—thymus cancer	0.000267	0.00909	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Telomerase—IL2—thymus cancer	0.000263	0.00895	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—CDKN2A—thymus cancer	0.000261	0.00889	CbGpPWpGaD
Sulindac—MAPK3—Alpha 6 Beta 4 signaling pathway—AKT1—thymus cancer	0.000254	0.00865	CbGpPWpGaD
Sulindac—MAPK3—Apoptosis Modulation and Signaling—CDKN2A—thymus cancer	0.00024	0.00818	CbGpPWpGaD
Sulindac—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—thymus cancer	0.000239	0.00813	CbGpPWpGaD
Sulindac—MAPK3—TCR Signaling Pathway—CD4—thymus cancer	0.000228	0.00777	CbGpPWpGaD
Sulindac—MAPK3—CXCR3-mediated signaling events—AKT1—thymus cancer	0.000227	0.00773	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—IL2—thymus cancer	0.000226	0.0077	CbGpPWpGaD
Sulindac—MAPK3—IL-5 Signaling Pathway—AKT1—thymus cancer	0.000218	0.00742	CbGpPWpGaD
Sulindac—MAPK3—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—thymus cancer	0.000214	0.00729	CbGpPWpGaD
Sulindac—MAPK3—ErbB2/ErbB3 signaling events—AKT1—thymus cancer	0.000214	0.00727	CbGpPWpGaD
Sulindac—MAPK3—IL-2 Signaling Pathway—AKT1—thymus cancer	0.00021	0.00713	CbGpPWpGaD
Sulindac—MAPK3—TWEAK Signaling Pathway—AKT1—thymus cancer	0.00021	0.00713	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—KIT—thymus cancer	0.000209	0.00709	CbGpPWpGaD
Sulindac—MAPK3—Corticotropin-releasing hormone—IL2—thymus cancer	0.000207	0.00702	CbGpPWpGaD
Sulindac—MAPK3—IFN-gamma pathway—AKT1—thymus cancer	0.000206	0.007	CbGpPWpGaD
Sulindac—MAPK3—IL-6 signaling pathway—AKT1—thymus cancer	0.000206	0.007	CbGpPWpGaD
Sulindac—MAPK3—Interleukin-11 Signaling Pathway—AKT1—thymus cancer	0.000202	0.00687	CbGpPWpGaD
Sulindac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—thymus cancer	0.0002	0.0068	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—KIT—thymus cancer	0.0002	0.00679	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—KIT—thymus cancer	0.000196	0.00668	CbGpPWpGaD
Sulindac—MAPK3—Oxidative Stress Induced Senescence—CDKN2A—thymus cancer	0.000194	0.0066	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—MAML2—thymus cancer	0.000192	0.00653	CbGpPWpGaD
Sulindac—MAPK3—TSLP Signaling Pathway—AKT1—thymus cancer	0.000192	0.00652	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—thymus cancer	0.00019	0.00646	CbGpPWpGaD
Sulindac—MAPK3—Ceramide signaling pathway—AKT1—thymus cancer	0.000188	0.00641	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—KIT—thymus cancer	0.000188	0.00638	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—KIT—thymus cancer	0.000188	0.00638	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—KIT—thymus cancer	0.000187	0.00635	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—KIT—thymus cancer	0.000186	0.00632	CbGpPWpGaD
Sulindac—MAPK3—IL-3 Signaling Pathway—AKT1—thymus cancer	0.000185	0.00631	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—KIT—thymus cancer	0.000185	0.00629	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CYLD—thymus cancer	0.000184	0.00627	CbGpPWpGaD
Sulindac—MAPK3—Angiopoietin receptor Tie2-mediated signaling—AKT1—thymus cancer	0.000182	0.0062	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—IL2—thymus cancer	0.000182	0.00618	CbGpPWpGaD
Sulindac—MAPK3—Signaling events mediated by Stem cell factor receptor (c-Kit)—AKT1—thymus cancer	0.00018	0.00611	CbGpPWpGaD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—TP53—thymus cancer	0.000175	0.00596	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—KIT—thymus cancer	0.000174	0.00591	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	0.000174	0.00591	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—KIT—thymus cancer	0.000174	0.00591	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—KIT—thymus cancer	0.000172	0.00586	CbGpPWpGaD
Sulindac—MAPK3—IL-4 Signaling Pathway—AKT1—thymus cancer	0.000172	0.00583	CbGpPWpGaD
Sulindac—MAPK3—FGF signaling pathway—AKT1—thymus cancer	0.000172	0.00583	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—TP53—thymus cancer	0.000171	0.00581	CbGpPWpGaD
Sulindac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—thymus cancer	0.000171	0.00581	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—KIT—thymus cancer	0.000171	0.00581	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—KIT—thymus cancer	0.00017	0.00578	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—IL2—thymus cancer	0.000169	0.00576	CbGpPWpGaD
Sulindac—MAPK3—Cardiac Hypertrophic Response—AKT1—thymus cancer	0.000169	0.00575	CbGpPWpGaD
Sulindac—MAPK3—RANKL/RANK Signaling Pathway—AKT1—thymus cancer	0.000169	0.00575	CbGpPWpGaD
Sulindac—MAPK3—IL-1 signaling pathway—AKT1—thymus cancer	0.000169	0.00575	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—MAML2—thymus cancer	0.000166	0.00565	CbGpPWpGaD
Sulindac—MAPK3—Kit receptor signaling pathway—AKT1—thymus cancer	0.00016	0.00543	CbGpPWpGaD
Sulindac—MAPK3—Fc-epsilon receptor I signaling in mast cells—AKT1—thymus cancer	0.000156	0.00529	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—KIT—thymus cancer	0.000154	0.00524	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—CDKN2A—thymus cancer	0.000152	0.00518	CbGpPWpGaD
Sulindac—MAPK3—Integrins in angiogenesis—AKT1—thymus cancer	0.000152	0.00516	CbGpPWpGaD
Sulindac—MAPK3—Endothelins—AKT1—thymus cancer	0.000152	0.00516	CbGpPWpGaD
Sulindac—MAPK3—Alzheimers Disease—TP53—thymus cancer	0.00015	0.0051	CbGpPWpGaD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—AKT1—thymus cancer	0.000148	0.00503	CbGpPWpGaD
Sulindac—MAPK3—mTOR signaling pathway—AKT1—thymus cancer	0.000146	0.00497	CbGpPWpGaD
Sulindac—MAPK3—TSH signaling pathway—AKT1—thymus cancer	0.000146	0.00497	CbGpPWpGaD
Sulindac—MAPK3—AGE/RAGE pathway—AKT1—thymus cancer	0.000146	0.00497	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—TP53—thymus cancer	0.000145	0.00495	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—TP53—thymus cancer	0.000145	0.00495	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—AKT1—thymus cancer	0.000144	0.00491	CbGpPWpGaD
Sulindac—MAPK3—BCR signaling pathway—AKT1—thymus cancer	0.000144	0.00491	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—CD4—thymus cancer	0.000144	0.00488	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Telomerase—AKT1—thymus cancer	0.000143	0.00485	CbGpPWpGaD
Sulindac—MAPK3—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—thymus cancer	0.000143	0.00485	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—CDKN2A—thymus cancer	0.000136	0.00462	CbGpPWpGaD
Sulindac—MAPK3—Apoptosis Modulation and Signaling—TP53—thymus cancer	0.000134	0.00455	CbGpPWpGaD
Sulindac—MAPK3—Leptin signaling pathway—AKT1—thymus cancer	0.000132	0.00449	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—IL2—thymus cancer	0.00013	0.00441	CbGpPWpGaD
Sulindac—MAPK3—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—thymus cancer	0.000125	0.00426	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—AKT1—thymus cancer	0.000123	0.00418	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—AKT1—thymus cancer	0.000123	0.00418	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—thymus cancer	0.000121	0.00412	CbGpPWpGaD
Sulindac—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thymus cancer	0.00012	0.0041	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—KIT—thymus cancer	0.000118	0.00403	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—IL2—thymus cancer	0.000116	0.00396	CbGpPWpGaD
Sulindac—MAPK3—TCR Signaling Pathway—AKT1—thymus cancer	0.000114	0.00388	CbGpPWpGaD
Sulindac—MAPK3—Corticotropin-releasing hormone—AKT1—thymus cancer	0.000112	0.00381	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—AKT1—thymus cancer	0.000112	0.00381	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TP53—thymus cancer	0.000109	0.0037	CbGpPWpGaD
Sulindac—MAPK3—Oxidative Stress Induced Senescence—TP53—thymus cancer	0.000108	0.00367	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CYLD—thymus cancer	0.000107	0.00365	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—IL2—thymus cancer	0.000106	0.00359	CbGpPWpGaD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—AKT1—thymus cancer	0.000103	0.00351	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—CDKN2A—thymus cancer	0.000103	0.00349	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—IL2—thymus cancer	0.000102	0.00348	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—AKT1—thymus cancer	0.000101	0.00343	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL2—thymus cancer	0.000101	0.00342	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—AKT1—thymus cancer	9.92e-05	0.00338	CbGpPWpGaD
Sulindac—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thymus cancer	9.72e-05	0.00331	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—AKT1—thymus cancer	9.37e-05	0.00319	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—KIT—thymus cancer	8.86e-05	0.00302	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL2—thymus cancer	8.48e-05	0.00288	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—MAML2—thymus cancer	8.48e-05	0.00288	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TP53—thymus cancer	8.32e-05	0.00283	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TP53—thymus cancer	8.19e-05	0.00279	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—AKT1—thymus cancer	8.05e-05	0.00274	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—AKT1—thymus cancer	7.96e-05	0.00271	CbGpPWpGaD
Sulindac—MAPK3—Disease—MAML2—thymus cancer	7.87e-05	0.00268	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—AKT1—thymus cancer	7.83e-05	0.00266	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—AKT1—thymus cancer	7.61e-05	0.00259	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—TP53—thymus cancer	7.55e-05	0.00257	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—AKT1—thymus cancer	7.49e-05	0.00255	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	7.39e-05	0.00251	CbGpPWpGaD
Sulindac—MAPK3—Insulin Signaling—AKT1—thymus cancer	7.19e-05	0.00245	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—AKT1—thymus cancer	7.16e-05	0.00243	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—AKT1—thymus cancer	7.12e-05	0.00242	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—AKT1—thymus cancer	7.09e-05	0.00241	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—AKT1—thymus cancer	7.05e-05	0.0024	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—AKT1—thymus cancer	6.92e-05	0.00235	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—KIT—thymus cancer	6.76e-05	0.0023	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	6.63e-05	0.00226	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—AKT1—thymus cancer	6.63e-05	0.00226	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—AKT1—thymus cancer	6.63e-05	0.00226	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—AKT1—thymus cancer	6.58e-05	0.00224	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—AKT1—thymus cancer	6.52e-05	0.00222	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—AKT1—thymus cancer	6.49e-05	0.00221	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TP53—thymus cancer	6.46e-05	0.0022	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—CDKN2A—thymus cancer	6.43e-05	0.00219	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—AKT1—thymus cancer	6.31e-05	0.00214	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—AKT1—thymus cancer	6.28e-05	0.00214	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	6.24e-05	0.00212	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL2—thymus cancer	6.24e-05	0.00212	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	5.88e-05	0.002	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—CDKN2A—thymus cancer	5.75e-05	0.00196	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—AKT1—thymus cancer	5.73e-05	0.00195	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—TP53—thymus cancer	5.71e-05	0.00194	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—AKT1—thymus cancer	5.55e-05	0.00189	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MAML2—thymus cancer	5.51e-05	0.00187	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—IL2—thymus cancer	5.28e-05	0.0018	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD8A—thymus cancer	5.24e-05	0.00178	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CD4—thymus cancer	5.17e-05	0.00176	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—IL2—thymus cancer	4.93e-05	0.00168	CbGpPWpGaD
Sulindac—PTGS2—Disease—MAML2—thymus cancer	4.68e-05	0.00159	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—AKT1—thymus cancer	4.52e-05	0.00154	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	4.4e-05	0.0015	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TP53—thymus cancer	4.01e-05	0.00136	CbGpPWpGaD
Sulindac—MAPK3—Immune System—KIT—thymus cancer	3.93e-05	0.00134	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	3.71e-05	0.00126	CbGpPWpGaD
Sulindac—MAPK3—Disease—KIT—thymus cancer	3.63e-05	0.00124	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—thymus cancer	3.39e-05	0.00115	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—AKT1—thymus cancer	3.38e-05	0.00115	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—thymus cancer	3.2e-05	0.00109	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL2—thymus cancer	3.03e-05	0.00103	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD4—thymus cancer	3.01e-05	0.00102	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—AKT1—thymus cancer	2.92e-05	0.000995	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—AKT1—thymus cancer	2.92e-05	0.000993	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—AKT1—thymus cancer	2.86e-05	0.000974	CbGpPWpGaD
Sulindac—MAPK3—Disease—CD4—thymus cancer	2.78e-05	0.000945	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL2—thymus cancer	2.77e-05	0.000942	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—AKT1—thymus cancer	2.67e-05	0.000909	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—AKT1—thymus cancer	2.58e-05	0.000877	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—KIT—thymus cancer	2.54e-05	0.000865	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IL2—thymus cancer	2.54e-05	0.000864	CbGpPWpGaD
Sulindac—PPARD—Metabolism—AKT1—thymus cancer	2.27e-05	0.000773	CbGpPWpGaD
Sulindac—PTGS2—Disease—KIT—thymus cancer	2.16e-05	0.000735	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL2—thymus cancer	1.79e-05	0.000609	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD4—thymus cancer	1.65e-05	0.000562	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AKT1—thymus cancer	1.64e-05	0.000559	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—thymus cancer	1.63e-05	0.000555	CbGpPWpGaD
Sulindac—MAPK3—Immune System—AKT1—thymus cancer	1.5e-05	0.000511	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—AKT1—thymus cancer	1.49e-05	0.000508	CbGpPWpGaD
Sulindac—MAPK3—Disease—AKT1—thymus cancer	1.39e-05	0.000472	CbGpPWpGaD
Sulindac—ALB—Hemostasis—AKT1—thymus cancer	1.38e-05	0.000469	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—thymus cancer	1.15e-05	0.000391	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AKT1—thymus cancer	9.71e-06	0.00033	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AKT1—thymus cancer	8.7e-06	0.000296	CbGpPWpGaD
Sulindac—PTGS2—Disease—AKT1—thymus cancer	8.24e-06	0.00028	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AKT1—thymus cancer	6.9e-06	0.000235	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AKT1—thymus cancer	6.13e-06	0.000208	CbGpPWpGaD
Sulindac—ALB—Metabolism—AKT1—thymus cancer	5.59e-06	0.00019	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AKT1—thymus cancer	3.91e-06	0.000133	CbGpPWpGaD
